Study to Evaluate Albuterol and Hydrofluoroalkane in Subjects Ages 12 and Older With Asthma

Study Title
A Dose-ranging Study to Evaluate Albuterol and Hydrofluoroalkane in Subjects Ages 12 and Older With Persistent Asthma
Teva Identifier
ABS-AS-201
ClinicalTrials.gov Identifier
NCT01058863
Study Status
Completed
Trial Condition(s)
Asthma
Interventions
Drug: Albuterol Spiromaxֲ® | Drug: ProAirֲ® HFA | Other: Placebo Inhaler

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age group
Child, Adult, Older Adult
Age Range
12 Years and older
Trial Duration
02/01/2010 - 06/01/2010
Phase
Phase 2

Study Type

Interventional